Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation
Journal of Atherosclerosis and Thrombosis · 2023
DOI: 10.5551/jat.64010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2023. Verfasst von Masahiro Kimura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Koto Memorial Hospital, Shiga, Japan. Hauptthemen laut MEDLINE: Myocardial Infarction, Drug-Eluting Stents, Percutaneous Coronary Intervention, Hypertriglyceridemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
AIM: This study aimed to investigate the association between a combination of elevated triglyceride (TG) and reduced high-density lipoprotein cholesterol (HDL-C) levels and target lesion revascularization (TLR) following everolimus-eluting stent (EES) implantation. The adverse impact of clinical, lesion, and procedural characteristics on TLR in patients with elevated TG and reduced HDL-C levels was also assessed. METHODS: We retrospectively collected data on 3,014 lesions from 2,022 consecutive patients, who underwent EES implantation at Koto Memorial Hospital. Atherogenic dyslipidemia (AD) is defined as a combination of non-fasting serum TG ≥ 175 mg/dL and HDL-C <40 mg/dL. RESULTS: AD was observed in 212 lesions in 139 (6.9%) patients. The cumulative incidence of clinically driven TLR was significantly higher in patients with AD than in those without AD (hazard ratio [HR] 2.31, 95% confidence interval [CI] 1.43-3.73, P=0.0006). Subgroup analysis showed that AD increased the risk of TLR with the implantation of small stents (≤ 2.75 mm). Multivariable Cox regression analysis showed that AD was an independent predictor of TLR in the small EES stratum (adjusted HR 3.00, 95% CI 1.53-5.93, P=0.004), whereas the incidence of TLR was similar in the non-small-EES stratum, irrespective of the presence or absence of AD. CONCLUSIONS: Patients with AD had a higher risk of TLR after EES implantation, and this risk was greater for lesions treated with small stents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Koto Memorial Hospital, Shiga, Japan.
Zitieren
APA
Kimura, M., Takeda, T., Tsujino, Y., Matsumoto, Y., Yamaji, M., Sakaguchi, T., Maeda, K., Mabuchi, H., & Murakami, T. (2023). Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64010
Vancouver
Kimura M, Takeda T, Tsujino Y, Matsumoto Y, Yamaji M, Sakaguchi T, et al. Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation. Journal of Atherosclerosis and Thrombosis. 2023. doi:10.5551/jat.64010
BibTeX
@article{Kimura2023,
author = {Kimura, Masahiro and Takeda, Teruki and Tsujino, Yasushi and Matsumoto, Yuichi and Yamaji, Masayuki and Sakaguchi, Tomoko and Maeda, Keiko and Mabuchi, Hiroshi and Murakami, Tomoyuki},
title = {Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2023},
doi = {10.5551/jat.64010}
}
EUVIMED